Literature DB >> 14981436

Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001.

W Anthony Lee1, Jeffrey W Carter, Gilbert Upchurch, James M Seeger, Thomas S Huber.   

Abstract

OBJECTIVE: Small patient numbers, mixed data from clinical trials, and longitudinal series representing institutional learning curves have characterized previous studies of early outcomes after endovascular abdominal aortic aneurysm (AAA) repair. We compared the perioperative outcomes of endovascular and open surgical AAA repair in an unselected sample of patients in a single calendar year using a national administrative database.
METHODS: The 2001 National Inpatient Sample database was retrospectively reviewed. This database represents 20% of all-payer stratified sample of non-federal US hospitals. Patients older than 49 years were identified by primary diagnostic codes (International Classification of Disease, ninth revision [ICD-9], 441.4, intact, nonruptured AAA) and procedure codes (ICD-9 38.44 for open, 39.71 for endovascular repair). Patient demographic data (age, sex), comorbid conditions (ICD-9 coded), inpatient complications (ICD-9 coded), length of stay, final discharge disposition (home vs institution vs death), and hospital charges were examined with univariate and multivariate analyses.
RESULTS: In calendar year 2001, 7172 patients underwent either open (64%) or endovascular (36%) repair of intact, nonruptured AAAs. Despite comparable rates of preoperative comorbid conditions and a greater proportion of octogenarians (23% vs 16%%; P =.0001), morbidity (18% vs 29%; P =.0001) and mortality (1.3% vs 3.8%; P =.0001) were significantly lower for endovascular repair than for open repair. The median length of stay (2 vs 7 days; P =.0001) and the rate of discharge to an institutional facility versus home (6% vs 14%; P =.0001) were also much lower in the endovascular group than in the open repair group. At multivariate analysis, open AAA repair and age older than 80 years were strong independent predictors (P =.0001 for all) for death (open repair: odds ratio [OR], 3.3; 95% confidence interval [CI], 2.3-4.9; age: OR, 14.2; 95% CI, 3.5-58.1), complications (open repair: OR, 1.9; 95% CI, 1.7-2.1; age: OR, 1.9; 95% CI, 1.5-2.5), and not being discharged to home (open repair: OR, 3.4; 95% CI, 2.9-4.1; age: OR, 12.0; 95% CI, 7.0-20.4). Mean hospital charges were significantly greater (difference, $3337; P =.0009) for endovascular repair than for open repair. Extrapolated to the total number of endovascular AAA repairs performed during the single 2001 calendar year, this resulted in a staggering $50.3 million in additional hospital charges.
CONCLUSIONS: Endovascular repair of intact AAAs results in a significantly lower number of complications and deaths, shorter hospital stay, and improved likelihood of discharge to home, even in older patients, when compared with open surgical repair. These impressive gains in clinical outcome, however, are achieved at similarly impressive increases in health care costs.

Entities:  

Mesh:

Year:  2004        PMID: 14981436     DOI: 10.1016/j.jvs.2003.12.001

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  21 in total

Review 1.  Canadian Society for Vascular Surgery consensus statement on endovascular aneurysm repair.

Authors:  Thomas F Lindsay
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

2.  Disparities in the treatment and outcomes of vascular disease in Hispanic patients.

Authors:  Nicholas J Morrissey; Jeannine Giacovelli; Natalia Egorova; Annetine Gelijns; Alan Moskowitz; James McKinsey; Kenneth Craig Kent; Giampaolo Greco
Journal:  J Vasc Surg       Date:  2007-11       Impact factor: 4.268

3.  Targets to prevent prolonged length of stay after endovascular aortic repair.

Authors:  J Hunter Mehaffey; Damien J LaPar; Margret C Tracci; Kenneth J Cherry; John A Kern; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2015-09-12       Impact factor: 4.268

4.  Preoperative Coil Embolization to Aortic Branched Vessels for Prevention of Aneurysmal Sac Enlargement Following EVAR: Early Clinical Result.

Authors:  Genta Chikazawa; Hidenori Yoshitaka; Arudo Hiraoka; Koyu Tanaka; Norio Mouri; Kentaro Tamura; Toshinori Totsugawa; Atsuhisa Ishida; Taichi Sakaguchi
Journal:  Ann Vasc Dis       Date:  2013-05-10

5.  Influencing Factors for Abdominal Aortic Aneurysm Sac Shrinkage and Enlargement after EVAR: Clinical Reviews before Introduction of Preoperative Coil Embolization.

Authors:  Genta Chikazawa; Arudo Hiraoka; Toshinori Totsugawa; Kentaro Tamura; Atsuhisa Ishida; Taichi Sakaguchi; Hidenori Yoshitaka
Journal:  Ann Vasc Dis       Date:  2014-08-30

6.  Open Reintervention for Aneurysmal Sac Enlargement after EVAR.

Authors:  Genta Chikazawa; Arudo Hiraoka; Yuuki Hirai; Kentaro Tamura; Toshinori Totsugawa; Atsuhisa Ishida; Taichi Sakaguchi; Hidenori Yoshitaka
Journal:  Ann Vasc Dis       Date:  2014-08-30

7.  Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade.

Authors:  David C Brewster; John E Jones; Thomas K Chung; Glenn M Lamuraglia; Christopher J Kwolek; Michael T Watkins; Thomas M Hodgman; Richard P Cambria
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

8.  Defining perioperative mortality after open and endovascular aortic aneurysm repair in the US Medicare population.

Authors:  Marc L Schermerhorn; Kristina A Giles; Teviah Sachs; Rodney P Bensley; A James O'Malley; Philip Cotterill; Bruce E Landon
Journal:  J Am Coll Surg       Date:  2011-02-04       Impact factor: 6.113

9.  Defining high-risk patients for endovascular aneurysm repair.

Authors:  Natalia Egorova; Jeannine K Giacovelli; Annetine Gelijns; Giampaolo Greco; Alan Moskowitz; James McKinsey; K Craig Kent
Journal:  J Vasc Surg       Date:  2009-09-26       Impact factor: 4.268

10.  Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair.

Authors:  Kristina A Giles; Frank Pomposelli; Allen Hamdan; Mark Wyers; Ami Jhaveri; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2009-01-09       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.